BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 17969987)

  • 1. [Case of fatal liver failure due to anti-tuberculous therapy].
    Harada Y; Kawakami K; Koyama K; Yamaryo T; Kimura Y
    Kekkaku; 2007 Sep; 82(9):705-9. PubMed ID: 17969987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of tuberculosis in the adult].
    Schrappe M; Wassermann K; Kroegel C
    Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
    [No Abstract]   [Full Text] [Related]  

  • 5. Isoniazid induced gynaecomastia: a case report.
    Garg R; Vaibhav ; Mehra S; Prasad R
    Indian J Tuberc; 2009 Jan; 56(1):51-4. PubMed ID: 19402273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of drug-induced hyperuricaemia on renal function in Nigerians with pulmonary tuberculosis.
    Adebisi SA; Oluboyo PO; Okesina AB
    Afr J Med Med Sci; 2000; 29(3-4):297-300. PubMed ID: 11714010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
    Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
    Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
    Stout JE
    Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antituberculous therapy and acute liver function.
    Bourke SJ; White J; Stenton SC; Hendrick DJ
    Lancet; 1995 May; 345(8958):1171-2. PubMed ID: 7786347
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fulminant hepatitis during the therapy for tuberculous meningitis].
    Garavelli PL
    Recenti Prog Med; 1996 Dec; 87(12):597. PubMed ID: 9102699
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis.
    Guo N; Marra F; Fitzgerald JM; Elwood RK; Marra CA
    Eur Respir J; 2010 Jul; 36(1):206-8. PubMed ID: 20595167
    [No Abstract]   [Full Text] [Related]  

  • 12. Antituberculous therapy-induced fulminant hepatic failure: successful treatment with liver transplantation and nonstandard antituberculous therapy.
    Idilman R; Ersoz S; Coban S; Kumbasar O; Bozkaya H
    Liver Transpl; 2006 Sep; 12(9):1427-30. PubMed ID: 16933231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 32-year-old man with tuberculosis, fever, and rash.
    Story RE; Ditto AM
    Ann Allergy Asthma Immunol; 2004 May; 92(5):495-9. PubMed ID: 15191016
    [No Abstract]   [Full Text] [Related]  

  • 14. Death associated with rifampin and pyrazinamide 2-month treatment of latent mycobacterium tuberculosis.
    Medinger A
    Chest; 2002 May; 121(5):1710-2. PubMed ID: 12006469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The adverse effects of 2 therapy combinations (SM, PAS, INH, RMP, INH, EMB) in the intensive treatment phase of pulmonary tuberculosis].
    Knop P; Kindler U; Merholz T
    Med Welt; 1976 Feb; 27(8):389-90. PubMed ID: 1256308
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple small bowel perforations in a patient on treatment of tuberculosis.
    Scriven JM; Berry D
    J R Coll Surg Edinb; 1996 Oct; 41(5):353. PubMed ID: 8908966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
    Mbaye PS; Talarmin F; Sane M; Eladari D; Klotz F
    Dakar Med; 1995; 40(2):129-31. PubMed ID: 9827070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid.
    Durand F; Bernuau J; Pessayre D; Samuel D; Belaiche J; Degott C; Bismuth H; Belghiti J; Erlinger S; Rueff B
    Hepatology; 1995 Apr; 21(4):929-32. PubMed ID: 7705802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isonicotinic acid hydrazide induced anagen effluvium and associated lichenoid eruption.
    Sharma PK; Gautam RK; Bhardwaj M; Kar HK
    J Dermatol; 2001 Dec; 28(12):737-41. PubMed ID: 11804071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of pulmonary tuberculosis with acute renal failure caused by readministration of rifampicin].
    Kuroda F; Yagi T; Yamagishi F; Mizutani F; Sasaki Y; Wada A
    Kekkaku; 1999 Nov; 74(11):803-7. PubMed ID: 10599213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.